Found: 18
Select item for more details and to access through your institution.
Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1999, v. 43, n. 1, p. 77, doi. 10.1093/jac/43.suppl_1.77
- By:
- Publication type:
- Article
A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1999, v. 43, n. 1, p. 67, doi. 10.1093/jac/43.suppl_1.67
- By:
- Publication type:
- Article
A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy withco-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1999, v. 43, n. suppl_1, p. 67, doi. 10.1093/jac/43.suppl_1.67
- By:
- Publication type:
- Article
Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxisduring transurethral surgery.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1999, v. 43, n. suppl_1, p. 77, doi. 10.1093/jac/43.suppl_1.77
- By:
- Publication type:
- Article
Utilization of Colistin Versus β-Lactam and β-Lactamase Inhibitor Agents in Relation to Acute Kidney Injury in Patients with Severe Gram-Negative Infections.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 1, p. 187, doi. 10.1007/s40121-021-00556-x
- By:
- Publication type:
- Article
Understanding the regulatory hurdles for antibacterial drug development in the post-Ketek world.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1241, n. 1, p. 153, doi. 10.1111/j.1749-6632.2011.06300.x
- By:
- Publication type:
- Article
US FDA's Assessment of the Benefit-risk of Cefiderocol for its Initial Complicated Urinary Tract Infection Indication.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Difficult to Treat: Do We Need a New Definition?
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 1, p. 141, doi. 10.1093/cid/cix246
- By:
- Publication type:
- Article
New Antimicrobial Agents . . . but No Susceptibility Tests!
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens – The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study.
- Published in:
- Infection & Drug Resistance, 2019, v. 12, p. 3607, doi. 10.2147/IDR.S225553
- By:
- Publication type:
- Article
The selection of appropriate dosages for intravenous ciprofloxacin.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Comparative serum bactericidal activity of ceftizoxime/metronidazole, ceftizoxime, clindamycin, and imipenem against obligate anaerobic bacteria.
- Published in:
- 1990
- By:
- Publication type:
- journal article
The Use of an Antibiotic Order Form for Antibiotic Utilization Review: Influence on Physicians' Prescribing Patterns.
- Published in:
- Journal of Infectious Diseases, 1984, v. 150, n. 6, p. 803
- By:
- Publication type:
- Article
Ciprofloxacin versus Cefuroxime Axetil in the Treatment of Acute Bacterial Sinusitis.
- Published in:
- Journal of Otolaryngology, 1999, v. 28, n. 1, p. 3
- By:
- Publication type:
- Article
Ciprofloxacin versus Cefuroxime Axetil in the Treatment of Adult Patients with Acute Bacterial Sinusitis.
- Published in:
- Journal of Otolaryngology, 1998, v. 27, n. 1, p. 10
- By:
- Publication type:
- Article
Clinical Trial Design and Consequences for Drug Development for Community-Acquired Pneumonia: An Industry Perspective.
- Published in:
- Clinical Infectious Diseases, 2008, v. 47, p. S237, doi. 10.1086/591408
- By:
- Publication type:
- Article
Clinical Trial Design for Mild-to-Moderate Community-Acquired Pneumonia—An Industry Perspective.
- Published in:
- Clinical Infectious Diseases, 2008, v. 47, p. S166, doi. 10.1086/591399
- By:
- Publication type:
- Article